Osteoarthritis Injections: Types Used in India

This piece covers the evidence base behind each of these osteoarthritis names, how the three categories differ in mechanism and expected duration of effect, and where India's regulatory framework treats them differently.

What is a corticosteroid injection for osteoarthritis, and how well does it work?

Intra-articular corticosteroid injections deliver a synthetic anti-inflammatory steroid directly into the joint space, reducing local inflammation that drives osteoarthritic pain. A systematic review and meta-analysis of randomised controlled trials found a short-term benefit over placebo on both pain and function measured at six weeks or less.

That same meta-analysis found the effect reversed over longer follow-up: at 24 weeks or more, results trended toward the control group performing as well as or better than the corticosteroid group. This is the pharmacological basis for corticosteroid injections being positioned as a short-term flare management tool rather than a disease-modifying or long-term maintenance therapy.

What is a hyaluronic acid injection, and when does it help?

Hyaluronic acid injections replace or supplement the joint's natural lubricating fluid, a substance that becomes thinner and less effective in osteoarthritic joints. A systematic review covering 38 randomised controlled trials found moderate efficacy for pain relief and functional improvement, most consistently in early-to-moderate osteoarthritis rather than advanced disease.

Patients with early-stage disease showed improvement within the first four weeks in several of the reviewed trials, while patients with advanced osteoarthritis in the same body of evidence showed worsening patient-reported outcomes over the same period. That divide, disease stage rather than injection brand, is the clinically relevant variable determining whether hyaluronic acid is a reasonable option for a given patient.

What is PRP, and what does the evidence actually show?

Platelet-rich plasma is prepared from a patient's own blood, concentrated to raise the platelet count above baseline. It is then injected into the joint on the premise that platelet-derived growth factors support tissue repair.

The evidence for PRP in knee osteoarthritis is more inconsistent than for corticosteroids or hyaluronic acid. A PMC review notes that dosing and preparation protocol are the biggest source of variability between studies reporting benefit and studies reporting none. An international systematic review of clinical practice guidelines on intra-articular injections for knee osteoarthritis found PRP recommendations varied by professional body, with several bodies declining to make a firm recommendation for or against use given the lack of standardisation across commercial PRP preparation kits and protocols.

How is PRP regulated differently from stem cell therapies in India?

PRP and autologous chondrocyte or osteocyte implantation fall outside the scope of the Indian Council of Medical Research's National Guidelines for Stem Cell Research 2017, because the guidelines specifically classify them as "other cell-based applications," distinct from stem cell transplantation. That places PRP in a regulatory space with less codified national guidance than stem-cell-based orthopaedic interventions, which do fall under the 2017 framework's monitoring and ethics-review requirements.

For a hospital or clinic, that regulatory gap means PRP protocol standardisation, preparation kit choice, platelet concentration target, and injection technique, sits largely with institutional clinical governance rather than a single binding national standard.

A quick reference table of osteoarthritis names by category

The table below lines up the three osteoarthritis names covered above (corticosteroid, hyaluronic acid, and PRP) against their mechanism, the evidence supporting each, and how long a typical course of benefit lasts before a repeat injection or a different approach becomes necessary.

What does injection stocking mean for a hospital pharmacy?

Corticosteroid and hyaluronic acid injections are standard pharmacy stock items with defined shelf lives and cold-chain requirements in some formulations. PRP, by contrast, is prepared at the point of care from the patient's own blood and is not a stocked pharmacy item at all, which means the relevant hospital infrastructure question for PRP is lab/processing capability, not pharmacy shelf stock.

Our managed hospital pharmacy services guide covers how an in-house pharmacy keeps corticosteroid and hyaluronic acid formulations reliably stocked instead of sending an orthopaedic patient's prescription to an outside chemist. Our prescription leakage guide covers what that leakage costs a hospital when a patient's post-injection medication list is filled elsewhere. Our pharmacy inventory management guide covers cold-chain and expiry discipline for exactly these injectable formulations.

Sources

1. 1Role and Effectiveness of Intra-articular Injection of Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Systematic Review — National Institutes of Health, National Library of Medicine
2. 2Efficacy of intra-articular corticosteroid injections in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials — PubMed, National Library of Medicine
3. 3Platelet-rich plasma in osteoarthritis treatment: review of current evidence — National Institutes of Health, National Library of Medicine
4. 4Indian National Guidelines for Stem Cell Research (2017) — Indian Council of Medical Research and Department of Biotechnology
5. 5Burden of osteoarthritis in India and its states, 1990–2019: findings from the Global Burden of Disease Study 2019 — Osteoarthritis and Cartilage

This article is for informational purposes and is not a substitute for professional medical advice. It describes injection categories and their evidence base for clinical reference; it does not recommend a specific treatment for any individual patient. Consult a qualified orthopaedic specialist for diagnosis and treatment planning.